| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 02/14/2008 | WO2007146066A3 Novel piperazines, pharmaceutical compositions and methods of use thereof |
| 02/14/2008 | US20080039627 Processes and intermediates for the preparations of prostaglandins |
| 02/14/2008 | US20080039626 Method for Cleaning 3-Hydroxyamidinophenylalanine Derivatives by the Precepitation and Recrystallization of Salt and an Aromatic Sulfonic Acid |
| 02/14/2008 | US20080039622 2,4-pyrimidinediamine compounds and their uses |
| 02/14/2008 | US20080039470 Acylaminoheteroaryl hepatitis C virus protease inhibitors |
| 02/14/2008 | US20080039450 Compounds |
| 02/14/2008 | US20080039446 Substituted isoindoles and their use |
| 02/14/2008 | US20080039442 Compounds With Kv4 Ion Channel Activity |
| 02/14/2008 | US20080039439 Alpha2C adrenoreceptor agonists |
| 02/14/2008 | US20080039426 2-(4-fluoro-2-methylphenylamino)-1,6-dimethyl-7-[3-(4-methyl-4-oxo-4 lambda 5[1,4]azaphosphinan-1-yl)-propenyl]-1,8-dihydro-imidazo[4,5-h]isoquinolin-9-one; anticancer agents, antiinflammatory agents, antiviral agents, anti-thromboembolic agents, as well as for treating autoimmune disease |
| 02/14/2008 | CA2661131A1 New heterocyclic compounds containing nitrogen atoms or pharmaceutically acceptable salts thereof, process for the preparation thereof and pharmaceutical composition comprising the same for treatment of cancer |
| 02/14/2008 | CA2660424A1 Sulfonamide compound or salt thereof |
| 02/14/2008 | CA2659599A1 Amino alcohol derivative and immunosuppressive agent having same as an active ingredient |
| 02/13/2008 | EP1885697A2 Soluble epoxide hydrolase inhibitors and methods of using same |
| 02/13/2008 | CN101124201A Parp抑制剂 Parp inhibitors |
| 02/12/2008 | US7329757 Chloroazinium compounds: 2-chloro-5-methyl-1-(3-trifluoromethyl-phenyl)-pyridinium chloride; intermediates for preparting iminoazine herbicides: N-cyclopropyl-5-methyl-1-(3-trifluoromethylphenyl)-2(1H)-pyridineimine |
| 02/12/2008 | CA2280270C Acrylonitrile compounds, process for their production and pesticides containing them |
| 02/12/2008 | CA2258701C Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders |
| 02/07/2008 | WO2008015429A2 Pharmaceutical compounds |
| 02/07/2008 | WO2008015423A1 Quinoline and quinoxaline n-oxides as chk-1 inhibitors |
| 02/07/2008 | WO2008014613A1 Multifunctional bioactive compounds |
| 02/07/2008 | WO2006105304A8 Phenyl and pyridyl lta4h modulators |
| 02/07/2008 | US20080032983 Ortho-Substituted N'-Benzylidene-(3-Hydroxyphenyl)Acethydrazides |
| 02/07/2008 | US20080032982 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis |
| 02/07/2008 | CA2659875A1 Multifunctional bioactive compounds |
| 02/06/2008 | EP1883622A1 Substituted aryl oximes |
| 02/06/2008 | CN100366605C Compounds to treat alzheimer's disease |
| 02/05/2008 | US7326731 Muscarinic agonists |
| 02/05/2008 | US7326710 Aralkyl formyl-alkyl piperazine derivatives and their uses as a cerebral nerve protective agent |
| 02/05/2008 | US7326707 Bicyclic melanocortin-specific compounds |
| 02/05/2008 | US7326706 Pyrazine modulators of cannabinoid receptors |
| 02/05/2008 | CA2339272C Nitrogen-containing heterocyclic carboxamide derivatives or salts thereof and antiviral agents comprising the same |
| 01/31/2008 | US20080027066 Arylpiperazinyl Compounds |
| 01/31/2008 | US20080027065 G protein coupled receptor inhibitors (Gpr38) such as 6-[(4-fluorophenyl)oxy]-N-methyl-N-(4-{[(3S)-3-methyl-1-piperazinyl]methyl}phenyl)-3-pyridinecarboxamide for treatment of gastric stasis in an enterally fed patient |
| 01/31/2008 | US20080027064 imidazo[1,5-a]pyrido[3,2-e]pyrazines; neurologic and psychiatric disorders, for example psychosis |
| 01/31/2008 | US20080027060 Dipeptide nitriles |
| 01/31/2008 | US20080027059 Substituted isoxazolines, pharmaceutical compositions containing same, methods of preparing same, and uses of same |
| 01/31/2008 | US20080027042 Novel Aminopyridine Derivatives Having Aurora a Selective Inhibitory Action |
| 01/30/2008 | CN101115727A Compounds useful for inhibiting chk1 |
| 01/30/2008 | CN101115726A Substituted piperazines as cb1 antagonists |
| 01/30/2008 | CN101115721A Indenyl derivatives and use thereof for the treatment of neurological disorders |
| 01/30/2008 | CN101115713A HIV protease inhibitors |
| 01/30/2008 | CN101113148A Dioxygen piperazidine compounds and preparation method and usage thereof |
| 01/29/2008 | US7323594 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
| 01/29/2008 | US7323484 Farnesyl transferase inhibitors |
| 01/29/2008 | US7323467 3-heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics |
| 01/24/2008 | WO2008009758A1 Compound that can inhibit ubc13-uev interactions, pharmaceutical compositions and therapeutic uses |
| 01/24/2008 | WO2007135131A8 Substituted pyrazinone derivatives for use as a medicine |
| 01/24/2008 | US20080021044 N-[2-[[(diaminomethylene)amino]oxy]ethyl]-3-[(2,2-difluoro-2-phenylethyl)amino]-6-methyl-2-oxo-1(2h)-pyrazineacetamide |
| 01/24/2008 | US20080021043 Piperidines and Related Compounds for Treatment of Alzheimer's Disease |
| 01/24/2008 | US20080021019 immunodeficiencies, cancers, cardiovascular diseases, endocrine disorders, Parkinson's disease, metabolic diseases, tumorigenesis, Alzheimer's disease, heart disease, diabetes, neurodegeneration, inflammation, kidney disease, atherosclerosis and airway disease; substituted pyrazine compounds |
| 01/24/2008 | CA2658327A1 Compound that can inhibit ubc13-uev interactions, pharmaceutical compositions and therapeutic uses |
| 01/23/2008 | EP1879864A1 Fluorinated pyridine n-oxide thrombin modulators and process for n-oxidation of nitrogen containing heteroaryls |
| 01/23/2008 | EP1879849A1 Process for preparing memantine |
| 01/23/2008 | EP1879564A2 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus |
| 01/23/2008 | EP1667635A4 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
| 01/23/2008 | EP1556354B1 Therapeutic piperazine derivates useful for treating pain |
| 01/23/2008 | EP1237880B1 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 01/23/2008 | EP1196404B1 Piperazine derivatives as modulators of chemokine receptor activity |
| 01/23/2008 | CN101111475A 抗病毒化合物及方法 Antiviral compounds and methods |
| 01/23/2008 | CN101108829A Method of producing 3- methyl group - quinoline -2- carboxylic acid |
| 01/23/2008 | CN100363364C Substituted hexahydropyrazino(1,2-a)pyrimidin-4,7-dion derivatives, method for the production and use thereof as medicaments |
| 01/22/2008 | CA2177651C Microbiological process for the preparation of heteroaromatic carboxylic acids using microorganisms of the genus alcaligenes |
| 01/17/2008 | US20080015203 Such as 3-[(1S)-2-hydroxy-1-methylethoxy]-5-[4-(methylsulfonyl)phenoxy]-N-1,3-thiazol-2-ylbenzamide; glucokinases (Glk) |
| 01/17/2008 | US20080015195 Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase |
| 01/17/2008 | US20080015193 Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof |
| 01/17/2008 | US20080015191 Pyrazines and Pyridines and Derivatives Thereof as Therapeutic Compounds |
| 01/17/2008 | US20080015172 Caspase inhibitors and uses thereof |
| 01/17/2008 | US20080012124 Curable protectant for electronic assemblies |
| 01/17/2008 | DE102006032591A1 Preparation of azo pigment containing melamine, useful e.g. to prepare printing colors and glue colors, comprises reacting a mixture of azobarbituric acid mono- and di- cation salt with a nickel compound and melamine |
| 01/16/2008 | EP1878728A2 Derivatives of piperazine and higher homologues thereof for the treatment of inflammation-related disorders |
| 01/16/2008 | EP1877385A1 Pyrimidines and pyrazines useful as modulators of ion channels |
| 01/16/2008 | EP1877377A2 Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles |
| 01/16/2008 | EP1877364A1 Phenylacetylene derivatives having mglur5 receptor affinity |
| 01/16/2008 | EP1687288B1 Substituted aryl cycloalkanol derivatives and methods of their use |
| 01/16/2008 | EP1567486B1 Bis-aryl sulfonamides |
| 01/16/2008 | EP1122242B1 Cyanophenyl derivatives |
| 01/16/2008 | CN101107226A Phenoxyacetic acid derivatives useful for treating respiratory diseases |
| 01/16/2008 | CN101107220A Amide derivatives as inhibitors of histone deacetylase |
| 01/16/2008 | CN101104606A Novel drought resisting agent and plant growth regulator |
| 01/15/2008 | US7319111 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists |
| 01/15/2008 | US7319104 hPPARs activators |
| 01/15/2008 | US7319099 Benzoyl-piperazine derivatives |
| 01/15/2008 | US7318966 Luminescent element material and luminescent element comprising the same |
| 01/10/2008 | WO2008003626A1 Theanine derivatives, uses thereof and processes for the manufacture thereof |
| 01/10/2008 | US20080009624 Heteroaryl carboxamides |
| 01/10/2008 | US20080009507 Cancer; such as 2-[4-(1-amino-1-methylethyl)phenyl]-3-(2-thienyl)-1,6-naphthyridin-5(6H)-one; serine/threonine kinase (Akt) suppression |
| 01/10/2008 | US20080009505 Theanine derivatives, uses thereof and processes for the manufacture thereof |
| 01/10/2008 | US20080009502 Tadalafil solid composites |
| 01/10/2008 | CA2657702A1 Quinazolines and related heterocyclic comp0unds, and their therapeutic use |
| 01/09/2008 | EP1874117A1 Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity |
| 01/09/2008 | EP1732887B1 1-(1h-indol-1-yl)-3-(4-methylpiperazin-1-yl)-1-phenyl propan-2-ol derivatives and related compounds as modulators of the norepinephrine (ne) and the serotonine (5-ht) activity and the monoamine reuptake for the treatment of vasomotor symptoms (vms) |
| 01/09/2008 | EP1620409B1 Quinoxalin-3-one derivatives as orexin receptor antagonists |
| 01/09/2008 | EP1129064B1 Transfection reagents |
| 01/09/2008 | CN101100525A Polyimide precursor, polyimide and application of the same |
| 01/09/2008 | CN101100513A 聚酰亚胺前体 Polyimide precursor |
| 01/09/2008 | CN101100512A 聚酰亚胺 Polyimide |
| 01/09/2008 | CN100360526C Aryl sulfonamides |
| 01/09/2008 | CN100360522C Novel compounds having selective inhibiting effect at GSK3 |
| 01/09/2008 | CN100360510C Process for producing oxycarbonyl-substituted piperazine derivative |